Gene · 406902
Papers3,238
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,238
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MicroRNAs: emerging biomarkers and therapeutic targets of bone fragility in chronic kidney disease. | Clin Kidney J | 2023 | 36865016 | PubTator, text mining | PubMed |
| The role of microRNAs in the molecular link between circadian rhythm and autism spectrum disorder. | Anim Cells Syst (Seoul) | 2023 | 36860270 | PubTator, text mining | PubMed |
| miRNA Signature of Urine Extracellular Vesicles Shows the Involvement of Inflammatory and Apoptotic Processes in Diabetic Chronic Kidney Disease. | Pharm Res | 2023 | 36859746 | PubTator, text mining | PubMed |
| Role of Circulating Exosomes in Cerebrovascular Diseases: A Comprehensive Review. | Curr Neuropharmacol | 2023 | 36847232 | PubTator, text mining | PubMed |
| Tumour‑derived exosomes and their emerging roles in leukaemia (Review). | Exp Ther Med | 2023 | 36845960 | PubTator, text mining | PubMed |
| Mechanism of action of non-coding RNAs and traditional Chinese medicine in myocardial fibrosis: Focus on the TGF-β/Smad signaling pathway. | Front Pharmacol | 2023 | 36843918 | PubTator, text mining | PubMed |
| Molecular mechanisms of atrazine toxicity on H19-7 hippocampal neurons revealed by integrated miRNA and mRNA "omics". | Ecotoxicol Environ Saf | 2023 | 36841081 | PubTator, text mining | PubMed |
| Coinfection of Dermal Fibroblasts by Human Cytomegalovirus and Human Herpesvirus 6 Can Boost the Expression of Fibrosis-Associated MicroRNAs. | Microorganisms | 2023 | 36838377 | PubTator, text mining | PubMed |
| Effect of 3D Spheroid Culturing on NF-κB Signaling Pathway and Neurogenic Potential in Human Amniotic Fluid Stem Cells. | Int J Mol Sci | 2023 | 36834995 | PubTator, text mining | PubMed |
| microRNAs (miRNAs) in Glioblastoma Multiforme (GBM)-Recent Literature Review. | Int J Mol Sci | 2023 | 36834933 | PubTator, text mining | PubMed |
| microRNAs Associated with Gemcitabine Resistance via EMT, TME, and Drug Metabolism in Pancreatic Cancer. | Cancers (Basel) | 2023 | 36831572 | PubTator, text mining | PubMed |
| Extracellular Vesicles and MicroRNA in Myelodysplastic Syndromes. | Cells | 2023 | 36831325 | PubTator, text mining | PubMed |
| The von Willebrand Factor Antigen Reflects the Juvenile Dermatomyositis Disease Activity Score. | Biomedicines | 2023 | 36831088 | PubTator, text mining | PubMed |
| Diagnostic and Prognostic Value of microRNAs in Patients with Laryngeal Cancer: A Systematic Review. | Noncoding RNA | 2023 | 36827542 | PubTator, text mining | PubMed |
| Advances in targeting of miR‑10‑associated lncRNAs/circRNAs for the management of cancer (Review). | Oncol Lett | 2023 | 36817057 | PubTator, text mining | PubMed |
| Breast cancer tumor microenvironment affects Treg/IL-17-producing Treg/Th17 cell axis: Molecular and therapeutic perspectives. | Mol Ther Oncolytics | 2023 | 36816749 | PubTator, text mining | PubMed |
| Comprehensive molecular and clinical characterization of NUP98 fusions in pediatric acute myeloid leukemia. | Haematologica | 2023 | 36815378 | PubTator, text mining | PubMed |
| MSC-Exos: Important active factor of bone regeneration. | Front Bioeng Biotechnol | 2023 | 36814713 | PubTator, text mining | PubMed |
| The PBX1/miR-141-miR-200a/EGR2/SOCS3 Axis; Integrative Analysis of Interaction Networks to Discover the Possible Mechanism of MiR-141 and MiR-200a-Mediated Th17 Cell Differentiation. | Iran J Biotechnol | 2023 | 36811100 | PubTator, text mining | PubMed |
| Inhibition of the epigenetically activated miR-483-5p/IGF-2 pathway results in rapid loss of meningioma tumor cell viability. | J Neurooncol | 2023 | 36809604 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406902/papers?page=18